About TwentyTwo
AI is making biology easy to engineer. Life-saving drugs and therapies are accelerating, but so is the ability for bad actors to create a pandemic. TwentyTwo is working on the defensive stack to prevent the next pandemic.
Company details
Funding
Last stage
Seed
Investors
Founders
Harmon Bhasin
CS graduate from UW-Madison; previously conducted biosecurity research with Kevin Esvelt at MIT and built biosurveillance software at SecureBio's Detection team. Focused on biosecurity, AI×Bio, and ML systems.
LinkedInDianzhuo (John) Wang
PhD from Harvard. Chief Scientific Officer at TwentyTwo. Research focused on AI-biosecurity, viral evolution, and interpretable machine learning tools for biological applications.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.